Medartis Holding AG Logo

Medartis Holding AG

MED | SW

Overview

Corporate Details

ISIN(s):
CH0386200239
LEI:
506700VUSP6HG3F28846
Country:
Switzerland
Address:
Hochbergerstr. 60E, 4057 Basel
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Medartis Holding AG is a global medical device company specializing in the development, manufacturing, and distribution of high-precision implants for the surgical fixation of bone fractures. The company provides a comprehensive portfolio of solutions, including titanium screws, plates, and surgical instruments, primarily for osteosynthesis. Its products are used for fractures and corrections in the upper and lower extremities, as well as for craniomaxillofacial surgeries. Medartis serves surgeons, hospitals, and medical centers worldwide, focusing on delivering innovative and technically advanced implants to improve patient outcomes.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Medartis Holding AG. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-19 06:58
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 58.8 KB
2025-08-19 02:00
Earnings Release
Medartis delivers 15.3% organic sales growth in H1 and lifts sales guidance for…
English 65.2 KB
2025-08-19 02:00
Earnings Release
Medartis erzielt im ersten Halbjahr ein organisches Umsatzwachstum von 15,3 % u…
German 67.9 KB
2025-07-30 09:59
Regulatory News Service
Medartis 2025 half-year results webcast
English 11.1 KB
2025-07-17 06:59
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 11.8 KB
2025-07-17 02:00
M&A Activity
Medartis acquires remaining 53% stake in KeriMedical
English 15.5 KB
2025-07-17 02:00
M&A Activity
Medartis erwirbt restliche 53 % der Anteile an KeriMedical
German 16.3 KB
2025-03-19 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 06:59
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 54.2 KB
2025-03-18 01:00
Earnings Release
Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA ma…
English 61.8 KB
2025-03-18 01:00
Earnings Release
Medartis erzielt 2024 ein Kernumsatzwachstum von 12 % und verbessert ihre Kern-…
German 63.2 KB
2024-08-20 07:05
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
English 51.0 KB
2024-08-20 02:00
Earnings Release
Medartis reports 13% revenue growth on Group level, driven by strong regional g…
English 45.2 KB
2024-08-20 02:00
Earnings Release
Medartis verzeichnet ein Umsatzwachstum von 13% auf Gruppenebene, angetrieben d…
German 48.8 KB
2024-07-09 06:59
Board/Management Information
Basel, 9th July 2024 Matthias Schupp appointed as CEO of Medartis
English 10.2 KB

Automate Your Workflow. Get a real-time feed of all Medartis Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Medartis Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-25 N/A Non-Executive member Buy None 176,411.02 CHF
2025-04-10 N/A Non-Executive member Buy None 37,500.00 CHF
2025-04-08 N/A Non-Executive member Buy None 375,000.00 CHF
2024-12-30 N/A Non-Executive member Buy None 4,999,956.00 CHF
2024-12-20 N/A Executive member Buy None 5,120.00 CHF
2024-12-19 N/A Executive member Buy None 5,300.00 CHF
2024-12-17 N/A Executive member Buy None 16,200.00 CHF
2024-12-16 N/A Executive member Buy None 2,214.00 CHF
2024-12-12 N/A Executive member Buy None 1,188.00 CHF
2024-12-11 N/A Executive member Buy None 72,795.60 CHF

Peer Companies

Company Country Ticker View
Biohit Oyj Logo
Develops diagnostic tests and lab systems for healthcare, research, and industrial laboratories.
Finland BIOBV
Bioretec Oy Logo
Develops bioabsorbable orthopedic implants for adults & pediatrics, eliminating removal surgeries.
Finland BRETEC
Bonesupport Holding Logo
Develops injectable bioceramic bone grafts that remodel into bone to heal fractures and voids.
Sweden BONEX
Bonyf N.V. Logo
Develops patented oral, dental, and dermatological care products for consumers and professionals.
Belgium MLBON
Boule Diagnostics Logo
Provides hematology analyzers and reagents for decentralized human and veterinary blood testing.
Sweden BOUL
BrainCool AB Logo
Develops medical cooling systems for therapeutic hypothermia to protect the brain and vital organs.
Sweden BRAIN
Carl Zeiss Meditec AG Logo
Medical tech leader in ophthalmology & microsurgery, offering lasers, lenses & visualization solutions.
Germany AFX
CARMAT Logo
Manufactures a bioprosthetic total artificial heart for end-stage heart failure patients.
France ALCAR
CellaVision Logo
Provides digital microscopy solutions to automate blood analysis for global hematology labs.
Sweden CEVI
Chordate Medical Holding AB Logo
Offers drug-free neuromodulation to treat chronic migraine and rhinitis in the EU & Middle East.
Sweden CMH